Back

Effect of sodium-glucose cotransporter-2 inhibitor (SGLT2-i) in patients with LVAD: a systematic review and meta-analysis

1 September 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Diabetes, obesity, and the heart Diuretics ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Elfatih A Hasabo

Galway (Ireland)

6 More presentations in this session

Presentation thumbnail
Dapagliflozin versus empagliflozin and major adverse cardiovascular events in type 2 diabetes: a nationwide cohort study
Doctor A. Alhakak (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
GLP1-RA versus DPP4 inhibitors on cardiovascular outcomes: A three-year real-world analysis
Doctor K. Soerensen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis
Doctor P. Theofilis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
Doctor J. Tjerkaski (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of SGLT2 inhibitor dapagliflozin on myocardial protein profile in rats with long-standing Type 1 diabetes mellitus
Doctor E. Rodrigues (Botucatu, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes, obesity, and the heart

The Event

Event poster

ESC Congress 2024

1 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of SGLT2-i in patients using LVAD: a systematic review and meta-analysis
thumbnail
Congress Presentation
Sglt2 inhibitors and outcomes in patients with diabetes after durable lvad implantation: a multicenter real-world cohort study
thumbnail
Congress Presentation
Beneficial SGLT2 inhibitors (SGLT2In) effects in patients with left ventricular assist device (LVAD)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources